Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility (CITaDeL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03986463
Recruitment Status : Completed
First Posted : June 14, 2019
Last Update Posted : February 18, 2021
Sponsor:
Information provided by (Responsible Party):
Lawson Health Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2020
Actual Study Completion Date : December 31, 2020